Literature DB >> 12057829

The Stereotypy Rating Inventory for frontotemporal lobar degeneration.

Kazue Shigenobu1, Manabu Ikeda, Ryuji Fukuhara, Naruhiko Maki, Kazuhiko Hokoishi, Akihiko Nebu, Takuo Yasuoka, Kenjiro Komori, Hirotaka Tanabe.   

Abstract

A many behavioral disturbances, Stereotypic behaviors are among the best discriminators of Frontotemporal Lobar Degeneration (FTLD). A recent preliminary report suggests many of the behavioral symptoms, including stereotypic behaviors in FTLD patients, respond to medication with selective serotonin re-uptake inhibitors. However, there is no scale that evaluates stereotypic behaviors comprehensively. To assess the wide range of stereotypic behaviors encountered in FTLD, we developed a new instrument, the Stereotypy Rating Inventory (SRI). The SRI assesses five distinctive stereotypic behavioral disturbances often seen in patients with FTLD: eating and cooking behaviors, roaming, speaking, movements, and daily rhythm. The SRI uses the same technique as the Neuropsychiatric Inventory (NPI) in that both the frequency and the severity of each behavior are determined. The studies reported here demonstrate the content and concurrent validity, as well as inter-rater and test-retest reliability, of the instrument. Scores of FTLD patients (n=26) on the SRI were much higher than those of patients with Alzheimer's disease (n=46), patients with vascular dementia (n=26), and normal control subjects (n=40). The SRI appears to be a useful instrument for detecting stereotypic behaviors and monitoring of therapies in FTLD patients.

Entities:  

Mesh:

Year:  2002        PMID: 12057829     DOI: 10.1016/s0165-1781(02)00094-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  Stereotypic behaviors in degenerative dementias.

Authors:  S Prioni; V Fetoni; F Barocco; V Redaelli; C Falcone; P Soliveri; F Tagliavini; A Scaglioni; P Caffarra; L Concari; S Gardini; F Girotti
Journal:  J Neurol       Date:  2012-05-31       Impact factor: 4.849

Review 2.  Parkinsonism, movement disorders and genetics in frontotemporal dementia.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2016-02-19       Impact factor: 42.937

3.  A study of stereotypic behaviours in Alzheimer's disease and frontal and temporal variant frontotemporal dementia.

Authors:  S Nyatsanza; T Shetty; C Gregory; S Lough; K Dawson; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

4.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

Authors:  Katya Rascovsky; John R Hodges; David Knopman; Mario F Mendez; Joel H Kramer; John Neuhaus; John C van Swieten; Harro Seelaar; Elise G P Dopper; Chiadi U Onyike; Argye E Hillis; Keith A Josephs; Bradley F Boeve; Andrew Kertesz; William W Seeley; Katherine P Rankin; Julene K Johnson; Maria-Luisa Gorno-Tempini; Howard Rosen; Caroline E Prioleau-Latham; Albert Lee; Christopher M Kipps; Patricia Lillo; Olivier Piguet; Jonathan D Rohrer; Martin N Rossor; Jason D Warren; Nick C Fox; Douglas Galasko; David P Salmon; Sandra E Black; Marsel Mesulam; Sandra Weintraub; Brad C Dickerson; Janine Diehl-Schmid; Florence Pasquier; Vincent Deramecourt; Florence Lebert; Yolande Pijnenburg; Tiffany W Chow; Facundo Manes; Jordan Grafman; Stefano F Cappa; Morris Freedman; Murray Grossman; Bruce L Miller
Journal:  Brain       Date:  2011-08-02       Impact factor: 13.501

5.  The pathophysiology of restricted repetitive behavior.

Authors:  Mark Lewis; Soo-Jeong Kim
Journal:  J Neurodev Disord       Date:  2009-06-16       Impact factor: 4.025

6.  Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia.

Authors:  Tiffany W Chow; Ariel Graff-Guerrero; Nicolaas Plg Verhoeff; Malcolm A Binns; David F Tang-Wai; Morris Freedman; Mario Masellis; Sandra E Black; Alan A Wilson; Sylvain Houle; Bruce G Pollock
Journal:  Neuropsychiatr Dis Treat       Date:  2011-07-13       Impact factor: 2.570

7.  Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders.

Authors:  Everard G B Vijverberg; Annemiek Dols; Welmoed A Krudop; Marta Del Campo Milan; Cora J Kerssens; Flora Gossink; Niels D Prins; Max L Stek; Philip Scheltens; Charlotte E Teunissen; Yolande A L Pijnenburg
Journal:  Alzheimers Dement (Amst)       Date:  2017-03-02

8.  Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?

Authors:  Shizuka Sakuta; Mamoru Hashimoto; Manabu Ikeda; Asuka Koyama; Akihiro Takasaki; Maki Hotta; Ryuji Fukuhara; Tomohisa Ishikawa; Seiji Yuki; Yusuke Miyagawa; Yosuke Hidaka; Keiichiro Kaneda; Minoru Takebayashi
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

Review 9.  Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders.

Authors:  Simon Ducharme; Annemiek Dols; Robert Laforce; Emma Devenney; Fiona Kumfor; Jan van den Stock; Caroline Dallaire-Théroux; Harro Seelaar; Flora Gossink; Everard Vijverberg; Edward Huey; Mathieu Vandenbulcke; Mario Masellis; Calvin Trieu; Chiadi Onyike; Paulo Caramelli; Leonardo Cruz de Souza; Alexander Santillo; Maria Landqvist Waldö; Ramon Landin-Romero; Olivier Piguet; Wendy Kelso; Dhamidhu Eratne; Dennis Velakoulis; Manabu Ikeda; David Perry; Peter Pressman; Bradley Boeve; Rik Vandenberghe; Mario Mendez; Carole Azuar; Richard Levy; Isabelle Le Ber; Sandra Baez; Alan Lerner; Ratnavalli Ellajosyula; Florence Pasquier; Daniela Galimberti; Elio Scarpini; John van Swieten; Michael Hornberger; Howard Rosen; John Hodges; Janine Diehl-Schmid; Yolande Pijnenburg
Journal:  Brain       Date:  2020-06-01       Impact factor: 13.501

10.  Effectiveness of Electroconvulsive Therapy for Depression and Cotard's Syndrome in a Patient with Frontotemporal Lobe Dementia.

Authors:  Toshiyuki Kobayashi; Koju Inoue; Katsutoshi Shioda; Satoshi Kato
Journal:  Case Rep Psychiatry       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.